Zhao J, Zhang H, Pan C, He Q, Zheng K, Tang Y
Mol Med Rep. 2024; 30(6).
PMID: 39422026
PMC: 11529173.
DOI: 10.3892/mmr.2024.13358.
Hsu C, Tsai C, Lin H, Chen H, Ou Y, Chiang P
J Cancer. 2024; 15(5):1213-1224.
PMID: 38356716
PMC: 10861814.
DOI: 10.7150/jca.90970.
Smith E, Huang M, Schlumbrecht M, George S, Xu X
Front Oncol. 2022; 12:907520.
PMID: 36185294
PMC: 9520484.
DOI: 10.3389/fonc.2022.907520.
Kim H
Medicina (Kaunas). 2022; 58(5).
PMID: 35630066
PMC: 9147666.
DOI: 10.3390/medicina58050649.
Smith E, Xu X
J Cancer Biol. 2022; 2(4):86-93.
PMID: 35048083
PMC: 8765745.
DOI: 10.46439/cancerbiology.2.031.
Discoidin Domain Receptor 2 Mediates Lysophosphatidic Acid-Induced Ovarian Cancer Aggressiveness.
Jeong B, Cho K, Yoon S, Park C, Park H, Lee H
Int J Mol Sci. 2021; 22(10).
PMID: 34065317
PMC: 8160857.
DOI: 10.3390/ijms22105374.
Nuclear Lamin A/C Expression Is a Key Determinant of Paclitaxel Sensitivity.
Smith E, Leal J, Amaya C, Li B, Xu X
Mol Cell Biol. 2021; 41(7):e0064820.
PMID: 33972393
PMC: 8224231.
DOI: 10.1128/MCB.00648-20.
Modulation of Immune Infiltration of Ovarian Cancer Tumor Microenvironment by Specific Subpopulations of Fibroblasts.
Wang J, Cheng F, Tedrow J, Chang W, Zhang C, Mitra A
Cancers (Basel). 2020; 12(11).
PMID: 33138184
PMC: 7692816.
DOI: 10.3390/cancers12113184.
Chaetomugilin J Enhances Apoptosis in Human Ovarian Cancer A2780 Cells Induced by Cisplatin Through Inhibiting Pink1/Parkin Mediated Mitophagy.
Hu X, Wang J, Chai J, Yu X, Zhang Y, Feng Y
Onco Targets Ther. 2020; 13:9967-9976.
PMID: 33116582
PMC: 7548334.
DOI: 10.2147/OTT.S273435.
Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology Approach.
Piga I, Verza M, Montenegro F, Nardo G, Zulato E, Zanin T
Front Oncol. 2020; 10:1277.
PMID: 32974128
PMC: 7466758.
DOI: 10.3389/fonc.2020.01277.
Exosomal miR-34b inhibits proliferation and the epithelial-mesenchymal transition by targeting Notch2 in ovarian cancer.
Lu S, Liu W, Shi H, Zhou H
Oncol Lett. 2020; 20(3):2721-2728.
PMID: 32782588
PMC: 7400462.
DOI: 10.3892/ol.2020.11837.
Serum amyloid a, a potential biomarker both in serum and tissue, correlates with ovarian cancer progression.
Li Z, Hou Y, Zhao M, Li T, Liu Y, Chang J
J Ovarian Res. 2020; 13(1):67.
PMID: 32517794
PMC: 7285470.
DOI: 10.1186/s13048-020-00669-w.
Systematic analysis of ovarian cancer platinum-resistance mechanisms via text mining.
Li H, Li J, Gao W, Zhen C, Feng L
J Ovarian Res. 2020; 13(1):27.
PMID: 32160916
PMC: 7066848.
DOI: 10.1186/s13048-020-00627-6.
Comparison of the Genomic Profile of Cancer Stem Cells and Their Non-Stem Counterpart: The Case of Ovarian Cancer.
Mazzoldi E, Pasto A, Pilotto G, Minuzzo S, Piga I, Palumbo P
J Clin Med. 2020; 9(2).
PMID: 32013179
PMC: 7073612.
DOI: 10.3390/jcm9020368.
[Comparison of serum cancer antigen 125, human epididymis protein 4, ROMA, and CPH-I for diagnosis of ovarian cancer in Chinese patients with ovarian mass].
Shipeng G, Yongning C, Yadi Z, Chanyuan L, Qifan J
Nan Fang Yi Ke Da Xue Xue Bao. 2020; 39(12):1393-1401.
PMID: 31907150
PMC: 6942985.
DOI: 10.12122/j.issn.1673-4254.2019.12.02.
Evaluation of the potential of a new ribavirin analog impairing the dissemination of ovarian cancer cells.
Wambecke A, Laurent-Issartel C, Leroy-Dudal J, Giffard F, Cosson F, Lubin-Germain N
PLoS One. 2019; 14(12):e0225860.
PMID: 31825993
PMC: 6905583.
DOI: 10.1371/journal.pone.0225860.
The ABO Blood Group is an Independent Prognostic Factor in Patients with Ovarian Cancer.
Song Q, Wu J, Wang S, Chen Z
J Cancer. 2019; 10(26):6754-6760.
PMID: 31777605
PMC: 6856877.
DOI: 10.7150/jca.36236.
Expression of the luteinizing hormone receptor (LHR) in ovarian cancer.
Xiong S, Mhawech-Fauceglia P, Tsao-Wei D, Roman L, Gaur R, Epstein A
BMC Cancer. 2019; 19(1):1114.
PMID: 31729966
PMC: 6857310.
DOI: 10.1186/s12885-019-6153-8.
Anti-Proliferative Effect of Wogonin on Ovary Cancer Cells Involves Activation of Apoptosis and Cell Cycle Arrest.
Zhao Q, Chang W, Chen R, Liu Y
Med Sci Monit. 2019; 25:8465-8471.
PMID: 31707402
PMC: 6865227.
DOI: 10.12659/MSM.917823.
Coiled-Coil and C2 Domain-Containing Protein 1A (CC2D1A) Promotes Chemotherapy Resistance in Ovarian Cancer.
Kumar S, Oien D, Khurana A, Cliby W, Hartmann L, Chien J
Front Oncol. 2019; 9:986.
PMID: 31632917
PMC: 6779793.
DOI: 10.3389/fonc.2019.00986.
